MCRB — Seres Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Seres Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	254	291	181	128	30.8
Net Total Accounts Receivable
Net Total Receivables	9.39	0	—	8.67	2.07
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	269	304	195	175	38.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22.9	36.1	134	132	92.4
Long Term Investments
Other Long Term Assets
Total Assets	343	355	349	359	140
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	46.4	82.3	85.6	98.7	41.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	168	223	338	403	126
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	175	132	10.8	-44.9	13.8
Total Liabilities & Shareholders' Equity	343	355	349	359	140
Total Common Shares Outstanding